-
Somite Therapeutics Announces FDA Orphan Drug and Rare Pediatric Disease Designations for SMT-M01 in Duchenne Muscular Dystrophy | Morningstar
ソース: Buzz FX / 16 9 2024 08:31:14 America/Chicago
[PR Newswire](/news/pr-newswire) Somite Therapeutics Announces FDA Orphan Drug and Rare Pediatric Disease Designations for SMT-M01 in Duchenne Muscular Dystrophy Somite Therapeutics Announces FDA Orphan Drug and Rare Pediatric Disease Desig
Read more...